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Abstract 
We report a case of a 59-year-old male patient with a postoperative fungal infection of the left 
eye. A dark-pigmented yeast, Exophiala dermatitidis (previously known as Wangiella 
dermatitidis) was identified from the culture of the biopsy taken from the posterior capsule. The 
infection was successfully eradicated by a combination of surgical and medical (i.e., 
voriconazole and fluconazole) treatment. This is the first report of successfully treated E. 
dermatitidis endophthalmitis, which demonstrates that a prompt and aggressive antifungal 
therapy combined with surgical intervention is necessary to prevent vision loss in cases of 
endophthalmitis due to Exophiala species. 
Beside the case description we also aim to provide a literature review of previously 
reported eye infections caused by Exophiala species in order to help the future diagnosis and 
management of the disease. 
 
Keywords: dematiaceous fungi, Exophiala, keratitis, endophthalmitis, antifungal susceptibility 
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Background 
Fungal eye infections are among the main causes of visual disability in tropical and subtropical 
countries, such as India. Besides hyaline fungal species, which are responsible for the majority of 
keratomycoses and fungal endophthalmitis in the country, dark-pigmented fungi are also 
associated with emerging cases [1,2]. The cosmopolitan genus Exophiala comprises dimorphic 
dematiaceous fungi commonly isolated from soil and plant debris [3,4]. These fungi are the 
clinically most relevant black yeasts causing various uncommon forms of cutaneous, 
subcutaneous and disseminated (e.g. pneumonia and brain abscess) human infections [5], but eye 
infections due to Exophiala species are extremely rare. Most cases occur after a penetrating 
injury or post eye surgery [6]. Though the presented case is the fourth documented case of 
endophthalmitis caused by E. dermatitidis across the globe according to a deep search of the 
available literature (Table 1) [7-18], it is unique, as it is the first report with a successful 
treatment outcome. Human ocular infection due to E. dermatitidis has not been documented in 
India before. 
 
Case presentation 
A 59-year-old male patient presented at the Cornea Department of Aravind Eye Hospital & 
Postgraduate Institute of Ophthalmology (Coimbatore, Tamilnadu, India) in December 2012 with 
complaints of decreased vision, pain and redness in his left eye for the past 15 days. The patient 
gave a history of an uneventful cataract surgery with intraocular lens implantation in his left eye 
performed four months earlier. He had good vision in the first month following surgery; i.e. 
visual acuity (VA) was 6/6. Three months later, he presented with gradual deterioration of vision 
(VA 6/60). The patient was otherwise in good health and had no known allergies. 
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On examination, the best corrected visual acuities were 6/6 in the right eye and 6/60 in the 
left eye. Intraocular pressure as measured by Goldmann applanation tonometry was 15 mm in the 
right eye and 13 mm in the left eye. Slit lamp examination of the right eye was within normal 
limits except for an early nuclear sclerotic cataract of grade 1. Examination of the left eye 
revealed circumcorneal congestion, a clear cornea and 3+ cells and 1+ flare in the anterior 
chamber. Texture and color of the iris were normal. The pupil was pharmacologically dilated and 
unresponsive to light. A posterior chamber intraocular lens was present, and a fluffy greyish 
white growth was noted on the posterior capsule (Fig. 1a, Fig. 1b). 
Indirect ophthalmoscopy of the right eye was within normal limits, but in the left eye 
moderate vitritis was observed. The patient underwent vitreous tap with a 24-gauge needle 
inserted into the central vitreous cavity along with intravitreal injections of moxifloxacin (500 
µg/0.1 ml; Vigamox, Alcon Laboratories, USA) and voriconazole (100 µg/0.1 ml; Aurolab, 
India). He was placed on topical moxifloxacin (0.5% (w/v); Vigamox, Alcon, India) and fortified 
tobramycin (14 mg/ml; Toba, Sun Pharma Laboratories Ltd., India) eight times a day, plus 
voriconazole (1% (w/v); Vozole, Aurolab, India) eye drops six times a day and homatropine (2% 
(w/v); Homide, Warren, India) eye drops twice a day. The topical treatment continued till the 
time of the intraocular lens removal (one month from the first vitreous tap). 
Vitreous biopsies obtained during the procedure were plated on 5% sheep blood agar 
(SBA; HiMedia Laboratories, India), potato dextrose agar (PDA; HiMedia Laboratories, India) 
and thioglycolate broth (HiMedia Laboratories, India). A part of the sample was sent for 
molecular identification (Xcyton Diagnostics Limited, Bengaluru, India). Gram stained smears 
and 10% potassium hydroxide wet mount were also investigated. The smears as well as the 
cultures proved to be negative for fungal filaments. Molecular analyses were negative for all the 
tested bacteria and fungi. Postoperatively the same medications were continued. Prednisolone 
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acetate (1% (w/v); Predforte, Allergan, India) was added at a frequency of six times a day. 
Dexamethasone (8 mg in 2 ml; Dexadran, Searle Labs Pvt. Ltd. India) was administered 
intravenously twice a day for two days and was subsequently replaced by oral prednisolone (40 
mg/day; Omnacortil, MacLeods Pharmaceuticals Ltd., India), tapered over a period of 15 days. 
On subsequent follow ups, the visual acuity was gradually improving (i.e. VA 6/9 after one 
week post-vitreous tap), but the anterior chamber inflammation persisted, and fluffy deposits on 
posterior surface of the intraocular lens persisted. Oral steroids were discontinued and the topical 
steroid dose (6 times per day; Predforte, Allergan, India) was tapered to four times. A repeated 
vitreous biopsy was performed on the ninth day following the first vitreous tap under local 
anesthesia using a 25-gauge vitreous cutter through the pars plana route. Care was taken to take 
the sample at the location of the fluffy growth with localized posterior capsulectomy and anterior 
vitrectomy. Specimens thus taken from the posterior capsule and anterior vitreous were plated on 
SBA, chocolate agar (CA; HiMedia Laboratories, India), PDA and Lowenstein Jensen medium 
(HiMedia Laboratories, India). A direct microscopic examination of Gram’s smears clearly 
revealed fungal filaments. The topical steroid therapy was stopped and the frequency of topically 
applied voriconazole (1% (w/v)) was increased to hourly intervals. The therapy was 
supplemented with oral fluconazole (150 mg; Zocon, FDC Limited, India) twice a day. On the 
fifth day of incubation, a moderate-sized black, mucoid and yeast-like growth was noted on 
SBA, CA and PDA plates. The fungus was initially identified as E. dermatitidis based on colony 
morphology (Fig. 2a) and microscopic features (Fig. 2b) and was further subjected to molecular 
identification. Medical treatment was continued for the next 10 days. The infiltrate reappeared in 
the inferonasal quadrant in-between the lens and the iris. Intraocular lens explantation, capsular 
bag removal with anterior vitrectomy was performed followed by an intravitreal voriconazole 
injection (100 µg /0.1 ml). Postoperatively, corneal edema and keratic precipitates were noted 
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which resolved after two weeks. Intravitreal injections of voriconazole (100 µg /0.1 ml) were 
repeated twice in the ensuing week for persistent exudates in the inferior vitreous. While topical 
voriconazole (1% (w/v)) was continued and slowly tapered over two months, systemic 
fluconazole (150 mg twice daily) was maintained for a month. After a month, topical steroids 
(Predforte, Allergan, India) were started with a very low dose twice a day, and tapered very 
slowly over the next four months. The best corrected Snellen’s visual acuity with aphakic 
correction was 6/9. 
For the molecular identification, genomic DNA was extracted using the MasterPure Yeast 
DNA Purification Kit (Epicentre Biotechnologies, USA) following the instructions of the 
manufacturer. PCR amplification was carried out by targeting the internal transcribed spacer 
(ITS) region using ITS1 and ITS4 primers [19]. The sequences were determined by LGC 
Genomics GmbH (Germany), the consensus of the two reads was assembled by using the Staden 
package (Pregap4 v.1.5 and Gap4 v4.10) [20] and manually edited in BioEdit [21]. The obtained 
592 bp long fragment was compared with the available sequences in the Genbank using the 
Basic Local Alignment Search Tool (BLAST) [22]. The isolate was finally identified as E. 
dermatitidis, as its ITS sequence displayed a 99% sequence homology with the ITS region of E. 
dermatitidis CBS 149.90 (Table 2). While the isolate itself was deposited in the Szeged 
Microbiological Collection (SZMC, Szeged, Hungary; http://szmc.hu/) under the strain number 
of SZMC 21989, its ITS sequence was deposited in the EMBL Nucleotide Sequence Database 
under the accession number of LN809939. 
The antifungal susceptibility profile of the case isolate was determined to 12 clinically 
relevant antifungal agents. The Etest method (BioMérieux, France) was used to determine the 
susceptibility to echinocandins (anidulafungin, caspofungin, micafungin), ketoconazole and 
posaconazole according to the instructions of the manufacturer. Minimum inhibitory 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 8 
concentration (MIC) values of the remaining seven antifungals were determined in accordance 
with the instructions of the CLSI (Clinical and Laboratory Standards Institute) M38-A2 broth 
microdilution method [23], with the involvement of the following commercially available 
standard powders and eye drops: amphotericin B, (Amphocare injection, BPRL Pvt ltd, 
Bangalore, India), clotrimazole (Auroclot, 1% (w/v) suspension, Aurolab, Madurai, India), 
econazole (Aurozole, 2% (w/v) suspension, Aurolab, Madurai, India), fluconazole (0.3% (w/v), 
Zocon, FDC ltd, Aurangabad, India), itraconazole (Itral, 1% (w/v) suspension, Jawa 
Pharmaceuticals, Guargon, India), natamycin (Natamet, 5% (w/v) suspension, Sun 
Pharmaceuticals Ind. Ltd., India) and voriconazole (Vfend, Pfizer Inc., India). Three replicates 
were involved in all the susceptibility tests. The obtained MIC values are summarized in Table 
3. MIC was defined as the lowest antifungal concentration, which was required for the total 
growth inhibition of the test isolate. Susceptibility testing revealed that the MICs of amphotericin 
B, clotrimazole, econazole, fluconazole, itraconazole, ketoconazole, posaconazole and 
voriconazole were >0.5 µg/ml, whereas, MICs for natamycin and echinocandin were 8 µg/ml 
and >32 µg/ml, respectively. 
 
Discussion and Conclusions 
According to the available literature in the PubMed database 
(http://www.ncbi.nlm.nih.gov/pubmed), only three Exophiala species, E. jeanselmei, E. 
dermatitidis and E. phaeomuriformis have been identified from various human eye infections 
such as keratitis, endophthalmitis and subconjunctival mycetoma in the last decades (Table 1). 
Until now, six Exophiala endophthalmitis cases have been reported from different parts of the 
world. The first case of endophthalmitis caused by E. dermatitidis was described by Margo et al. 
in 1990 [14]. Since then, two other cases were reported by Benaoudia et al. in 1999 [15] and 
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Clamp et al. in 2014 [17]. Medical therapy included surgical intervention supplemented with 
either intravitreal (2.5-5.0 µg) or intravenous (0.2-0.8 mg/kg) injections of amphotericin B in all 
cases. Benaoudia et al. [15] also used oral itraconazole (200 mg b.i.d.) and amphotericin B eye 
drops (0.15% (w/v) eight times a day). A failed therapeutic approach and consequent enucleation 
of the blind eyes were reported in the cases of Margo et al. [14] and Clamp et al. [17]. 
Endophthalmitis cases due to another species, E. jeanselmei were also treated with systemic and 
intraocular amphotericin B, but ocular atrophy developed in both cases [16]. These five, above 
mentioned patients suffered from different underlying disorders such as diabetes, Crohn's disease 
and purpura. Based on these prior reports of Exophiala eye infections (Table 1), underlying 
conditions seem to increase the chances of a failed therapy. Infections were eradicated in almost 
all seven cases of keratitis. Conversely, subconjunctival mycetoma and endophthalmitis cases 
usually had poor visual outcome. In comparison to previous reports, our patient had no other 
complaints, and after vitrectomy he was successfully treated with intravitreal injections and eye 
drops of voriconazole and oral fluconazole. Based on the experience, authors recommend prompt 
removal of the intraocular lens and capsular bag along with vitrectomy to eradicate the infection. 
Also in eyes with localized growth (like in our case), care should be taken to reach the area of 
growth when taking specimens for culture and staining to increase the chance of getting a 
positive yield unlike in routine endophthalmitis cases where the specimen is usually taken from 
the center of the vitreous cavity. In the presented case, the surgeon took utmost care to get the 
repeat specimen from the suspected area of the exudate as the first specimen proved to be 
negative.  
While in the 1990s mainly amphotericin B was chosen for the treatment of Exophiala eye 
infections, it was replaced in the last few years by new azole compounds, like voriconazole 
(Table 1). Unfortunately, limited data are available about the in vitro antifungal activity of these 
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new agents against Exophiala isolates derived from human eye infections. Based on the in vitro 
antifungal susceptibility tests, the case isolate had variable susceptibility to different antifungal 
drugs (Table 3). Basically, the obtained results agreed with the previous report of Chowdhary et 
al. [5], except from the finding that echinocandins (e.g., anidulafungin, caspofungin, micafungin) 
proved to be ineffective against the tested isolate in the investigated concentration range (MIC 
>32 µg/ml), while Chowdhary et al. [5] found a much lower MIC range (0.25-8 µg/ml) for E. 
dermatitidis strains. 
In conclusion, endophthalmitis due to E. dermatitidis is a rare but serious infection of the 
eye. Its management requires a radical surgical intervention for a successful outcome and also 
utmost care is necessary in collecting vitreous sample in eyes with localized infection to achieve 
higher culture positivity rate. The subsequent application of a carefully chosen, effective 
antifungal therapy is critical for a successful outcome. This case obviously demonstrates that 
besides Aspergillus [24], Curvularia [25] and Fusarium [26,27] species, Exophiala dermatitidis 
should also be taken into consideration as a causative agent of eye infections in South India. 
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Figure Legends: 
Fig. 1 Slit lamp biomicroscopy (a) with retro illumination (b) showing the fungal colonies on the 
posterior surface of the intraocular lens 
Fig. 2 Colony (a) and microscopic morphology (b) of Exophiala dermatitidis SZMC 21989 
cultured on Sabouraud's agar for 7 days. White arrows indicate terminal and intercalary phialids 
while black arrows indicate the yeast-like cells 
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Table 1 A retrospective summary of Exophiala eye infections reported since 1990. 
Aetiological agent Age/Gendera Country Therapyb Underlying conditionc Outcome Reference 
Keratitis 
E. dermatitidis 35/M 
Czechoslovak
ia 
AMB NF1, immunodeficiency Leukoma [7] 
E. jeanselmei 42/M Saudi Arabia NTM, MCN, AMB - Improved [8] 
E. jeanselmei 58/F Israel NTM, AMB - Improved [6] 
E. dermatitidis 52/M USA AMB - Improved [9] 
E. jeanselmei 39/F USA AMB, ITC - Improved [10] 
E. jeanselmei 41/M USA VRC, NTM, KTC, SI - Improved [11] 
E. phaeomuriformis 84/F USA VRC, SI - Improved [12] 
Subconjunctival mycetoma 
E. dermatitidis 44/F China SI - Improved [13] 
Endophthalmitis 
E. dermatitidis 75/F USA AMB, SI Diabetes Enucleation [14] 
E. dermatitidis 31/M France ITC, AMB, SI - Failed [15] 
E. jeanselmei 67/F Brazil AMB Purpura Atrophy [16] 
E. jeanselmei 52/F Brazil AMB Diabetes Atrophy [16] 
E. dermatitidis 60/M USA AMB,SI Crohn’s disease, Herpes zoster keratitis Enucleation [17] 
Exophiala sp. 65/F Puerto Rico VRC, FLC, SI Diabetes Improved [18] 
E. dermatitidis 59/M India VRC, FLC, SI - Improved Present case 
aF: female; M: male. 
bAMB: amphotericin B; FLC: fluconazole; ITC: itraconazole; KTC: ketoconazole; MCN: miconazole; NTM: natamycin; PSC: posaconazole; SI: surgical 
intervention; VRC: voriconazole. 
cNF1: neurofibromatosis type I. 
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Table 2 The top five results of nucleotide-nucleotide BLAST search performed with the ITS sequence of the case isolate in the 
National Center for Biotechnology Information database (NCBI, http://www.ncbi.nlm.nih.gov/). 
Species Isolate GenBank Accession No. 
Identities 
bp/bp % 
Exophiala dermatitidis CBS 149.90 AF050268 597/604 99% 
Exophiala dermatitidis PUMY063 JN391328 595/605 98% 
Exophiala dermatitidis WM 07.305 KP132044 594/605 98% 
Exophiala dermatitidis PWQ2207 KP132041 594/605 98% 
Exophiala dermatitidis PMM10-90L KP132040 594/605 98% 
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Table 3 Antifungal susceptibility profile of Exophiala dermatitidis isolate SZMC 21989. 
Antifungal agent Amphotericin B Anidulafungin Caspofungin Clotrimazole Econazole Fluconazole 
MIC (µg/ml) 0.33 >32 >32 0.33 0.83 2.67 
Antifungal agent Itraconazole Ketoconazole Micafungin Natamycin Posaconazole Voriconazole 
MIC (µg/ml) 0.25 0.25 >32 8 0.38 0.25 
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